spacer
home > > winter 2003 > translating the pharma industry
PUBLICATIONS


Translating the Pharma Industry

The value of translations produced in the UK is thought to be worth more than £161 million according to some definitive research carried out last year. This figure may seem relatively low value compared with the market worth of the pharmaceutical sector as a whole, but considering the volume of actual translation jobs needed to produce such a global figure, translation is far from being an insignificant net contributor to UK plc.

Let's get the rest of the statistics out of the way. The translation profession is split into two segments; companies, of which there are around 1,500, and individual freelancers. It is estimated that there are around 8,000 to 9,000 freelance translators, although there are probably more since many individuals who offer translation or interpreting services rarely join one of the recognised professional bodies. The Association of Translation Companies is the only body regulating the company sector of the profession.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Geoffrey Bowden, General Secretary of the Association of Translation Companies

Geoffrey Bowden has been the General Secretary of the Association of Translation Companies for 23 years. In addition to his role with the ATC, he runs a successful PR consultancy, Nexus Structured Communications, specialising in the health sector. The client base of the consultancy includes household names in the pharmaceutical industry.

spacer
Geoffrey Bowden
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Significant improvement in overall survival with ERLEADA®▼ (apalutamide) for patients with non-metastatic castration-resistant prostate cancer

BEERSE, BELGIUM, May 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the final analysis of the pivotal Phase 3 SPARTAN study demonstrating ERLEADA®▼ (apalutamide) in combination with androgen deprivation therapy (ADT) significantly improved overall survival (OS), compared to ADT alone, in patients with non-metastatic castration-resistant prostate cancer (nmCRPC) who were at high risk of developing metastases.1 Results will be presented at the American Society of Clinical Oncology (ASCO) Virtual Scientific Programme (Abstract #5516) beginning on Friday 29th May.
More info >>

White Papers

High Containment FIBCs Offer a Safe and Cost Effective Alternative to their Rigid Counterparts

ILC Dover

As the need for powder containment and manufacturing in accordance with cGMP standards has grown over the years, companies have sought new alternatives to rigid IBCs. Recently high containment Flexible Intermediate Bulk Containers (FIBCs) have emerged which offer an alternative that provides both powder containment and the benefits of shipping with flexibles.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement